4
Patent Litigation Has Many Aspects PARA IV Plus brings all these facets together and offers: Litigation Outcome Post excl. competition Generic win / loss At risk launch Settlement Forfeiture of excl. Excl. triggered by non-FTF FTF vs. Innovator Non FTF vs. Innovator Citizen’s Petition Patent reissue / withdrawal Generic vs. Generic Non OB Patents 1. A product by product comprehensive understanding as regards its litigation and also measures taken outside of courts and action taken by various stakeholders (like settlements, Citizen Petitions, authorized generics etc.) 2. Identifying cases that are not litigated and claims of generics accepted by innovators – something that never comes to the public domain until the generic is launched. 3. A clear picture of “who seems to be losing and who is winning”. 4. An attempt to anticipate (and not speculate) to find ‘what could be next’, including possible settlements, possible at risk launches, possible launches as per undisclosed settlement dates based on the facts on table. 5. To a legal expert this information set can help identify those Para IV opportunities where there is still upside potential even after 180-day exclusivity is already awarded to another company. 6. To a fund manager, this helps in anticipating the possible outcome sufficiently in advance to take meaningful investment decisions. P ARA IV Plus TM P ARA IV Plus TM MP Advisors Patent Litigation
